Grifols reported EUR23.29B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
aTyr Pharma USD 106.65M 5.12M Sep/2025
GlaxoSmithKline GBP 61.34B 2.08B Sep/2025
Grifols EUR 23.29B 3.35M Sep/2025